Douglas A. Rich
Net worth: 9 617 $ as of 2023-11-29
Career history of Douglas A. Rich
Former positions of Douglas A. Rich
| Companies | Position | Start | End |
|---|---|---|---|
| APPLIED MOLECULAR TRANSPORT INC. | Chief Tech/Sci/R&D Officer | 2021-01-18 | 2023-12-26 |
Boehringer Ingelheim Corp.
 Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | Corporate Officer/Principal | 2010-12-31 | 2013-12-31 |
| UNITY BIOTECHNOLOGY, INC. | Chief Operating Officer | 2017-03-31 | - |
| KYTHERA BIOPHARMACEUTICALS INC | Chief Operating Officer | 2014-04-30 | - |
Training of Douglas A. Rich
| University of Southern California | Undergraduate Degree |
| Pepperdine University | Masters Business Admin |
Statistics
International
| United States | 7 |
Operational
| Chief Operating Officer | 2 |
| Undergraduate Degree | 1 |
| Masters Business Admin | 1 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| UNITY BIOTECHNOLOGY, INC. | Health Technology |
| APPLIED MOLECULAR TRANSPORT INC. | Health Technology |
| Private companies | 2 |
|---|---|
Kythera Biopharmaceuticals LLC
 Kythera Biopharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Kythera Biopharmaceuticals LLC operates as a clinical-stage biopharmaceutical company. It focuses on the discovery, development, and commercialization of novel prescription products for the aesthetic medicine market. The company was founded by Jay Edward Birnbaum, Amit D. Munshi, Nathaniel Eames David, and Keith R. Leonard, Jr. on June 3, 2004 and is headquartered in Westlake, CA. | Health Technology |
Boehringer Ingelheim Corp.
Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | Health Technology |
- Stock Market
- Insiders
- Douglas A. Rich
- Experience
